Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-06-28
1998-03-10
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530307, A61K 3800, A61K 3802, A61K 3830, C07K 500
Patent
active
057261547
ABSTRACT:
Compositions and methods for stabilization and oral delivery of human calcitonin are described. An aqueous liquid composition for stable storage of human calcitonin comprises an aqueous mixture of SDS and an organic acid. An nonaqueous liquid composition for stable storage of human calcitonin comprises about 90-100% by volume of a mixture of C.sub.8 /C.sub.10 mono- and di-glycerides and about 0-10% by volume of a polar, nonaqueous solvent. Both of these stabilized human calcitonin formulations provided significant intestinal absorption of calcitonin.
REFERENCES:
patent: 4654132 (1987-03-01), Takagi et al.
patent: 4954342 (1990-09-01), Lattanzi et al.
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5120710 (1992-06-01), Liedtke
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5183746 (1993-02-01), Shaked et al.
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5288498 (1994-02-01), Stanley et al.
patent: 5350741 (1994-09-01), Takada
patent: 5430021 (1995-07-01), Rudnic et al.
patent: 5444041 (1995-08-01), Owen et al.
patent: 5571788 (1996-11-01), Arvinte et al.
patent: 5633226 (1997-05-01), Owen et al.
J. DeRose, M.D., Response of Paget's Disease to Porcine and Salmon Calcitonins, 56 Amer. Journal of Medicine, 858-866 (1974).
V. Fatourechi, M.D. et al. Salmon Calcitonin in the Treatment of Postmenopausal Osteoporosis, 107 Annals of Internal Medicine 923-925 (1987).
D.J. Hosking, Treatment of Sever Hypercalcaemia with Calcitonin, 2, Metab. Bone Dis. & Rel. Res. 207-212 (1980).
H. E. Gruber et al., Long-Term Calcitonin Therapy in Postmenopausal Osteoporosis, 33 Metabolism 295-303 (1984).
J. H. Carstens, Jr. et al., Future Horizons for Calcitonin: A U.S. Perspective, 49 Calcif Tissue Int. S2-S6 (1991).
S. J. Heiber, et al., In-Vivo Buccal Delivery of Calcitonin, 28 J. Control. Release 269-271 (1994).
J. Hastewell et al., Absorption of human calcitonin across the rat colon in vivo, 82, Clinical Science 589-594 (1992).
K. Overgaard et al., Rectal Salmon Calcitonin for the Treatment of Postmenopausal Osteoporosis, 51, Calcif. Tissue Int. 184-188 (1992).
S. Kobayashi et al., Pulmonary Delivery of Salmon Calcitonin Dry Powders Containing Absorption Enhancers in Rats, 13 Pharmaceutical Research 80-83 (1996).
J. P. Devogelaer et al., Comparison of the Acute Biological Action of Injectable Salmon Calcitonin and an Injectable and Oral Calcitonin Analogue (1994).
R. Muff, Ph.D., et al., Efficacy of Intranasal Human Calcitonin in Patients with Paget's Disease Refractory to Salmon Calcitonin 89 The American Journal of Medicine 181-184 (1990).
P. Sieber et al., 255 Menschliches Calcitonin. VI). Die Synthese von Calcitonin M.sup.2), 53 Helvetica Chemica Acta 2135-2150 (1970).
T. Arvinte et al., The Structure and mechanism of Fomration of Human Calcitonin Fibrils, 268 The Journal of Biological Chemistry 6415-6422 (1993).
R. Maier, et al., Analogues of Human Calcitonin, 85 Acta Endocrinlogica 102-108 (1977).
Paul Becher and Martin J. Schick, Macroemulsions Nonionic Surfactant Physical Chemistry 439-56 (Marcel Dekker, NW 1987).
A. Helenius & K. Simons, Solubilization of Membranes by detergents, 415 Biochim. Biophys, Acta 29-79 (1975).
L. Hovgaard et al., Insulin Stabilization and GI Absorption 19 J. Control. Release 99-108 (1992).
M. Baudys et al., Stabilization and Intestinal Absorption of Human Calcitonin, 1266 Journal of Controlled Release 1-7 (1996).
Karyn F. Thompson and Lila M. Gierasch. Conformation of a Peptide Solubilizate in a Reversed Micelle Water Pool, 106 J. Am. Chem. Soc. 3648-3652 (1984).
P. L. Luisi et al, Reverse micelles as hosts for proteins and small molecules, 947 Biochimica et Biophysica Acta 109-246 (1988).
Baudys Miroslav
Kim Sung Wan
Borin Michael L.
Tsang Cecilia J.
University of Utah Research Foundation
LandOfFree
Stabilization and oral delivery of calcitonin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilization and oral delivery of calcitonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilization and oral delivery of calcitonin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139380